-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Downgrades Pediatrix Medical Group to Underperform, Maintains Price Target to $28

Benzinga·11/11/2026 10:53:59
Listen to the news
Mizuho analyst Ann Hynes downgrades Pediatrix Medical Group (NYSE:MD) from Neutral to Underperform and maintains the price target from $28 to $28.